You are on page 1of 9

Posttraumatic stress disorder: Epidemiology, pathophysiology, clinical manifestations, and diagnosis Authors Paul Ciechanowski, MD Wayne Katon, MD Section

Editor Murray B Stein, MD, MPH Deputy Editor Richard Hermann, MD All topics are updated as new evidence becomes available and our peer review process is complete. Literature review current through: Jan 2013. | This topic last updated: Nov 30, 2012. INTRODUCTION Posttraumatic stress disorder (PTSD) has been described as "the complex somatic, cognitive, affective and behavioral effects of psychological trauma" [1]. PTSD is characterized by intrusive thoughts, nightmares and flashbacks of past traumatic events, avoidance of reminders of trauma, hypervigilance, and sleep disturbance, all of which lead to considerable social, occupational, and interpersonal dysfunction. The diagnosis of PTSD can be challenging because of the heterogeneity of the presentation and resistance on the part of the patient to discuss past trauma. The diagnosis of PTSD is made in the subset of people who have experienced trauma who are unable to cope with the consequences of trauma and whose well-being over time is greatly impacted by these consequences. Concerns have been expressed about the potential to "over-medicalize" normal reactions to trauma, on one hand, while failing to recognize and address PTSD, on the other [2]. Pharmacotherapy and psychotherapy of PTSD are discussed separately. The epidemiology, pathophysiology, clinical manifestations, diagnosis, and treatment of PTSD with dissociative features are also discussed separately. The epidemiology, pathophysiology, clinical manifestations, diagnosis, and treatment of acute stress disorder are also discussed separately. (See "Pharmacotherapy for posttraumatic stress disorder" and "Psychotherapy for posttraumatic stress disorder" and "Dissociative aspects of posttraumatic stress disorder: Epidemiology, clinical manifestations, and diagnosis" and "Acute stress disorder: Epidemiology, clinical manifestations, and diagnosis" and "Treatment of acute stress disorder".) EPIDEMIOLOGY Many different types of trauma have been found to result in PTSD, including those listed below. Many of these events are common, resulting in a large number of affected individuals.

Military combat Violent personal assault Natural and man-made disasters Severe motor vehicle accidents Rape Incest Childhood sexual abuse Diagnosis of a life-threatening illness Severe physical injury Hospitalization in an intensive care unit (ICU) Prevalence and susceptibility The lifetime prevalence of PTSD ranges from 6.8 to 12.3 percent in the general adult population in the United States (US) [3-5], with one-year

prevalence rates of 3.5 to 6 percent [3,6,7]. In a study of 368 patients from a community primary care clinic, 65 percent reported a history of exposure to severe, potentially traumatic events; 12 percent went on to develop PTSD [8]. Personal and societal factors appear to affect both the likelihood of developing PTSD after a traumatic event and the clinical presentation of PTSD [2,9]. Risk factors for PTSD include lower socioeconomic status, parental neglect, family or personal history of a psychiatric condition, poor social support, and initial severity of reaction to the traumatic event [10-12]. In a study of male patients treated in primary care, Veterans Administration (VA) practices, 36 percent of patients who had been diagnosed with major depression screened positive for PTSD [13]. Trauma exposure and PTSD have also been associated with physical illness [14]. In a population-based study of 3171 community respondents, PTSD was associated with increased risks for angina (OR 2.4, 95% CI 1.3, 4.5), heart failure (OR 3.4, 95% CI 1.9, 6.0), bronchitis, asthma, liver, and peripheral artery disease (ORs range = 2.5, 3.1) after adjusting for sociodemographic factors, smoking, body mass index, blood pressure, depression, and alcohol use disorders [14]. The frequency with which PTSD occurs after a traumatic event is influenced by characteristics of the individual and the inciting event [15]. Overall, women are four times more likely to develop PTSD than men, after adjusting for exposure to traumatic events [10]. The rates of PTSD are similar among men and women after events s uch as accidents (6.3 versus 8.8 percent), natural disasters (3.7 versus 5.4 percent), or sudden death of a loved one (12.6 versus 16.2 percent). Although women are more than 10 times as likely as men to be raped, the incidence of PTSD after rape is higher in men (65 versus 46 percent). The rate of PTSD is lower in men than in women after events such as molestation (12.2 versus 26.5 percent) and physical assault (1.8 versus 21.3 percent). Higher rates of PTSD have been found in subgroups in the US compared to the general population, including Native Americans living on reservations and refugees from countries where traumatic stress was endemic. In two large samples of Native Americans, lifetime prevalence of PTSD ranged from 14.2 to 16.1 percent [16]. Among Cambodian refugees two decades after resettling in the US, 62 percent met criteria for PTSD in the last year [17]. Sexual assault Sexual assault is the most frequent type of trauma experienced by women with PTSD [3,18]. In a nationally representative sample of 4,008 women in the United States (US), the lifetime prevalence of PTSD was 12.3 percent. Of the women who had a history of PTSD, 32 percent had been raped and 31 percent experienced a sexual assault other than rape [3]. (See "Evaluation and management of adult sexual assault victims".) Mass conflict and displacement A meta-analysis of 145 studies of 64,332 refugees and other conflict-affected individuals internationally found a mean PTSD prevalence rate of 30.6 percent (95% CI, 26.3 - 35.2 percent) [19]. Factors associated with higher PTSD rates included reported torture, cumulative exposure to potentially traumatic events, shorter time since conflict, and the assessed level of political terror. Combat PTSD occurring after combat injury appears to be strongly correlated with the extent of injury, and develops over several months [20]. Rates of a positive screen for PTSD were higher when US veterans were surveyed three to six months following return from active duty, compared to results of surveys immediately on return [21]. In addition, up to 60 percent of returning soldiers with a positive PTSD screen on their initial survey reported symptom improvement by three to six months.

In another study of US soldiers hospitalized for war-related injuries, the prevalence of PTSD was 4.2 percent at one month and 12.2 percent by four months post-injury. Soldiers with a high severity of physical problems a month after injury were at greater risk of PTSD six months later, compared to those with lower physical problem severity (OR 7.0, 95% CI 3.1-16.0). Almost one-half of soldiers with war-related mild traumatic brain injury (concussion syndrome) met criteria for PTSD in one study; ongoing symptoms that had been attributed to direct effects of the brain injury may in fact relate to PTSD and be amenable to appropriate treatment [22]. War-related PTSD has been associated with long-term consequences for mental health [23]. A longitudinal cohort study compared a random sample of 450 Australian Vietnam veterans with matched subjects from the Australian general population. When assessed 36 years after the war, veterans with war-related PTSD were more likely than members of the general population to have depression, an anxiety disorder (eg, social phobia, panic disorder, agoraphobia with or without panic disorder, and specific blood phobia), alcohol dependence, or persistent pain disorder. ICU hospitalization A systematic analysis of 15 studies found the prevalence of PTSD in patients who survived intensive care unit (ICU) hospitalization to be approximately 20 percent [24]. Predictors of PTSD included prior psychopathology and greater use of benzodiazepines in the ICU; severity of critical illness was not a predictor of PTSD. (See "Overview of inpatient management in trauma patients".) Myocardial infarction A meta-analysis of 24 observational studies including 2383 patients who experienced an acute coronary syndrome (ACS; ie, a myocardial infarction or unstable angina) found a prevalence rate of ACS-induced PTSD of 12 percent (95% CI 9-16 percent) [25]. Data from three studies of 609 patients that met quality criteria for the meta-analysis showed found that patients experiencing ACS-induced PTSD had a two-fold risk of subsequent mortality or ACS recurrence (risk ratio = 2; 95% CI 1.69 2.37) compared to ACS patients who did not experience PTSD symptoms. (See "Overview of the non-acute management of ST elevation myocardial infarction" and "Overview of the non-acute management of unstable angina and non-ST elevation myocardial infarction".) Cost Extensive analyses of the cost of PTSD are rare, but suggest that PTSD is associated with increased health care costs and other direct and indirect costs. One study that looked at women with PTSD in a health maintenance organization (HMO) found that compared with women with few symptoms of PTSD, women with moderate and severe PTSD symptoms had increased median annual health care costs (38 and 104 percent higher, respectively) [26]. Exposure to trauma itself appears to be extremely costly in terms of the impact upon victims and their families and upon society. In one study, for example, severely victimized women in an HMO setting had medical expenses twice that of controls [27]. Other reports have estimated direct annual costs of personal crime in the US nationally to be $105 billion (medical costs, lost earnings, victim assistance programs); that figure increases to $450 billion annually when intangible losses (pain, suffering, quality of life) are considered [28]. PATHOPHYSIOLOGY While much of the pathophysiology of PTSD is unclear, interesting research findings are accruing. Studies using MRI scans have shown that there is decreased volume of the hippocampus, left amygdala, and anterior cingulate cortex in patients with PTSD compared with matched controls [29,30]. Other reports have demonstrated increased central norepinephrine levels with down-regulated central adrenergic receptors [31], chronically decreased glucocorticoid levels with up-regulation of their receptors (possibly accounting for the anecdotal finding that there are more autoimmune diseases in these patients), and hemispheric lateralization in which there is a relative failure of left hemispheric function (possibly accounting for confusion related to time sequence of traumatic events) [32].

Researchers suspect that genetics may contribute to an individual's susceptibility to PTSD through an interaction with environmental factors [33]. However, research studies on the genetics of PTSD have generally been small and findings have been inconclusive [34]. As an example of a potential gene-environment interaction, the presence of one of four polymorphisms at the stress-related gene FKBP5 was found to be associated with an increased risk for PTSD in patients with a history of child abuse, but not in patients without history of child abuse [35]. Previous exposure to trauma appears to increase the risk of developing PTSD with subsequent traumatic events [36]. The mechanism by which this "sensitization" occurs is unclear. A study of severely injured accident victims who were healthy before experiencing trauma found that the incidence of PTSD was low [37]. CLINICAL MANIFESTATIONS Most individuals who experience trauma react to some degree when experiencing reminders of the trauma. Patients with PTSD, however, experience marked cognitive, affective, and behavioral responses to stimuli, leading to flashbacks, severe anxiety, and fleeing or combative behavior. These individuals compensate for such intense arousal by attempting to avoid experiences that may begin to elicit symptoms; this can result in emotional numbing, diminished interest in everyday activities and, in the extreme, may result in detachment from others. There are important distinguishing characteristics of PTSD symptoms in patients who experienced most of their trauma in childhood (eg, physical and sexual abuse) [1]. Compared with controls, these individuals often show greater difficulty with affect regulation (eg, unmodulated anger), and often demonstrate more dissociation, somatization, self-destructive behavior, and suicidal behavior. Co-occurring conditions Psychiatric comorbidity is high in patients with PTSD. The National Comorbidity Survey data suggests that 16 percent have one coexisting psychiatric disorder, 17 percent have two psychiatric disorders, and 50 percent have three or more [4]. Depressive disorders, anxiety disorders, and substance abuse are two to four times more prevalent in patients with PTSD; substance abuse is often due to the patient's attempts to self-medicate symptoms [4]. Traumatic brain injury (TBI) and PTSD have high rates of co-occurrence among civilians and, particularly, among soldiers who suffer combat-related TBI [38]. As an example, 11 percent of American soldiers returning from combat in Iraq and Afghanistan were reported to screen positive for PTSD in 2008. Among returning soldiers with mild TBI, 62 percent screened positive for PTSD [39]. Studies suggest that somatization disorder is as much as 90 times more likely in patients with PTSD than in patients without the disorder [40]. (See "Somatization: Epidemiology, pathogenesis, clinical features, medical evaluation, and diagnosis".) Course Most individuals who develop PTSD experience its onset within a few months of the traumatic event. However, epidemiologic studies have found that approximately 25 percent experience a delayed onset after six months or more [41]. PTSD is commonly a chronic condition with only one-third of patients recovering at one year follow-up, and one-third still symptomatic ten years after the exposure to the trauma [4]. Individuals with one or more PTSD symptoms are more likely to experience occupational problems, have poorer social supports, and have more disability than controls [42]. PTSD may increase the risk for attempted suicide [43,44]. Individuals with PTSD have higher rates of problems in intimate relationships, including marital difficulties, compared to people without PTSD [42,45].

Individual psychotherapy has been found to improve overall psychosocial functioning [46]. Accumulating evidence suggests that cognitive-behavioral conjoint therapy for individuals with PTSD and their partners is an effective strategy for reducing PTSD symptom severity and increasing intimate relationship satisfaction [47]. (See "Psychotherapy for posttraumatic stress disorder", section on 'Couples therapy'.) DIAGNOSIS Patients presenting with symptoms of PTSD should receive a comprehensive psychiatric assessment. A diagnosis of PTSD is made for patients who meet all of the criteria below from the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR); (table 1) [48].

A severe, traumatic event causing intense fear or helplessness Resulting symptoms in each of three categories Reexperiencing Avoidance Arousal Social or occupational impairment Symptoms and functional impairment lasting more than one month after the trauma Examples of questions a clinician can ask to elicit symptoms are provided below.

How do you feel when you recall the event? Do you experience dreams or flashbacks about it? Do you find yourself avoiding people or activities you associate with the event? Do you find yourself forgetting occurrences from that period? Do you find yourself looking carefully around when you are in a public place? Patients need to be asked specific questions about their traumatic experience(s) to differentiate PTSD from other psychiatric disorders. These questions should be asked with sensitivity. Patients are often reluctant to discuss past traumatic events because of guilt, embarrassment, or discomfort inherent in revisiting painful memories. Patients may minimize their symptoms of PTSD. Some patients may feel that past trauma has little or no effect on present symptoms. Military personnel in the US have been reported to be reluctant to disclose PTSD symptoms due to stigmatization and fear of professional repercussions [49]. Patients diagnosed with PTSD should also be assessed for suicidal or parasuicidal ideation or acts and co-occurring psychiatric conditions, substance use disorders, and medical conditions. Instruments for screening and monitoring In screening patients for PTSD, eg, primary care patients, returning veterans, or individuals experiencing domestic violence, particular attention should be paid to individuals presenting with new anxiety, fear, or insomnia [50]. Furthermore, clinicians may want to pay attention to associated behaviors in individuals at risk for PTSD anxiety symptoms, such as social isolation, increased substance abuse (alcohol and/or tobacco), or attempts at distraction through excessive work. The PTSD checklist (PCL) may be helpful in screening patients for PTSD and monitoring the progress of treatment over time [51]. Versions of this tool have been developed for civilian and military populations (form 1 and form 2). For differing populations, the sensitivity of the PCL ranges from .69 to .94 and the specificity is from .83 to .99 [5254]. A score of 50 out of a maximum score of 85 is associated with a diagnosis of PTSD. While the PCL is self-administered by patients, another option for assessing severity is the Clinician-Administered PTSD Scale (CAPS) [55].

Differentiating acute stress disorder Individuals presenting with symptoms of posttraumatic stress and functional impairment after a highly traumatic event are diagnosed as having acute stress disorder (ASD) for the first 30 days following the event. Most people recover completely within this period. For those who remain symptomatic (at the threshold established by DSM-IV-TR criteria), their diagnosis is then reclassified as PTSD. INFORMATION FOR PATIENTS UpToDate offers two types of patient education materials, The Basics and Beyond the Basics. The Basics patient education pieces are written in plain language, at the 5 th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, th th and more detailed. These articles are written at the 10 to 12 grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon. Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on patient info and the keyword(s) of interest.)

Basics topic (see "Patient information: Post-traumatic stress disorder (The Basics)") SUMMARY AND RECOMMENDATIONS

The one-year prevalence of PTSD ranges from 3.5 to 6 percent in the US general adult population. (See 'Epidemiology' above.) Many different types of trauma can result in PTSD, including military combat, sexual or physical assault, disasters, childhood sexual abuse, severe physical injury, and ICU hospitalization. (See 'Epidemiology' above.) The pathophysiology of PTSD is not well understood. However, differences in neuroanatomy, neurotransmitters, and brain functioning have been found in individuals with the disorder. (See 'Pathophysiology' above.) Individuals with PTSD experience marked cognitive, affective, and behavioral responses to stimuli reminding them of trauma they experienced, eg, flashbacks, severe anxiety, and fleeing or combative behavior. They compensate for this intense arousal through avoidance, emotional numbing, and diminished interest in people and activities. (See 'Clinical manifestations' above.) PTSD is commonly accompanied by comorbid psychiatric conditions, including depression, substance use disorders, and somatization. (See 'Co-occurring conditions' above.) Diagnostic criteria for PTSD include: experiencing a severe, traumatic event causing intense fear; resulting symptoms in each of three categories (reexperiencing trauma, avoiding trauma-associated stimuli, and increased arousal); social or occupational impairment; and symptoms and impairment lasting at least one month after the trauma (table 1). (See 'Diagnosis' above.) A diagnosis of PTSD is made only after a month has passed since the traumatic event. Prior to that time, patients with PTSD-like symptoms and functional impairment are diagnosed with acute stress disorder. (See 'Diagnosis' above.) Use of UpToDate is subject to the Subscription and License Agreement. REFERENCES van der Kolk BA, Pelcovitz D, Roth S, et al. Dissociation, somatization, and affect 1 dysregulation: the complexity of adaptation of trauma. Am J Psychiatry 1996; 153:83.

Stein DJ, Seedat S, Iversen A, Wessely S. Post-traumatic stress disorder: medicine and politics. Lancet 2007; 369:139.

Resnick HS, Kilpatrick DG, Dansky BS, et al. Prevalence of civilian trauma and 3 posttraumatic stress disorder in a representative national sample of women. J Consult Clin Psychol 1993; 61:984. 4 Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995; 52:1048.

Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 125 month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:617. Norris FH. Epidemiology of trauma: frequency and impact of different potentially 6 traumatic events on different demographic groups. J Consult Clin Psychol 1992; 60:409. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset 7 distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593. 8 9 10 11 Stein MB, McQuaid JR, Pedrelli P, et al. Posttraumatic stress disorder in the primary care medical setting. Gen Hosp Psychiatry 2000; 22:261. Kroll J. Posttraumatic symptoms and the complexity of responses to trauma. JAMA 2003; 290:667. Vieweg WV, Julius DA, Fernandez A, et al. Posttraumatic stress disorder: clinical features, pathophysiology, and treatment. Am J Med 2006; 119:383. Liebschutz J, Saitz R, Brower V, et al. PTSD in urban primary care: high prevalence and low physician recognition. J Gen Intern Med 2007; 22:719.

12 Bisson JI. Post-traumatic stress disorder. BMJ 2007; 334:789. Campbell DG, Felker BL, Liu CF, et al. Prevalence of depression-PTSD comorbidity: 13 implications for clinical practice guidelines and primary care-based interventions. J Gen Intern Med 2007; 22:711. Spitzer C, Barnow S, Vlzke H, et al. Trauma, posttraumatic stress disorder, and 14 physical illness: findings from the general population. Psychosom Med 2009; 71:1012. 15 Yehuda R. Post-traumatic stress disorder. N Engl J Med 2002; 346:108. Beals J, Manson SM, Whitesell NR, et al. Prevalence of DSM-IV disorders and 16 attendant help-seeking in 2 American Indian reservation populations. Arch Gen Psychiatry 2005; 62:99. G. N. Marshall, T. L. Schell, M. N. Elliott, S. M. Berthold, and C. A. Chun. Mental 17 health of Cambodian refugees 2 decades after resettlement in the United States. JAMA 2005; 294:571. Chivers-Wilson KA. Sexual assault and posttraumatic stress disorder: a review of the 18 biological, psychological and sociological factors and treatments. Mcgill J Med 2006; 9:111. Steel Z, Chey T, Silove D, et al. Association of torture and other potentially traumatic 19 events with mental health outcomes among populations exposed to mass conflict and displacement: a systematic review and meta-analysis. JAMA 2009; 302:537. 20 Grieger TA, Cozza SJ, Ursano RJ, et al. Posttraumatic stress disorder and depression in battle-injured soldiers. Am J Psychiatry 2006; 163:1777.

Milliken CS, Auchterlonie JL, Hoge CW. Longitudinal assessment of mental health 21 problems among active and reserve component soldiers returning from the Iraq war. JAMA 2007; 298:2141. 22 23 Hoge CW, McGurk D, Thomas JL, et al. Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med 2008; 358:453. O'Toole BI, Catts SV, Outram S, et al. The physical and mental health of Australian Vietnam veterans 3 decades after the war and its relation to military service,

combat, and post-traumatic stress disorder. Am J Epidemiol 2009; 170:318. Davydow DS, Gifford JM, Desai SV, et al. Posttraumatic stress disorder in general 24 intensive care unit survivors: a systematic review. Gen Hosp Psychiatry 2008; 30:421. Edmondson D, Richardson S, Falzon L, et al. Posttraumatic stress disorder 25 prevalence and risk of recurrence in acute coronary syndrome patients: a metaanalytic review. PLoS One 2012; 7:e38915. 26 27 Walker EA, Katon W, Russo J, et al. Health care costs associated with posttraumatic stress disorder symptoms in women. Arch Gen Psychiatry 2003; 60:369. Koss MP, Woodruff WJ, Koss PG. Criminal victimization among primary care medical patients: prevalence, incidence, and physician usage. Behav Sci Law 1991; 9:85.

Miller, TR, Cohen, MA, Wiersma, B. Victim costs and consequences: A new look. 28 United States Department of Justice, National Institute of Justice, Research Report, Washington, DC 1996. Bremner JD, Randall P, Scott TM, et al. MRI-based measurement of hippocampal 29 volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995; 152:973. 30 31 32 Karl A, Schaefer M, Malta LS, et al. A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev 2006; 30:1004. Geracioti TD Jr, Baker DG, Ekhator NN, et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 2001; 158:1227. van der Kolk BA. The psychobiology of posttraumatic stress disorder. J Clin Psychiatry 1997; 58 Suppl 9:16.

Kilpatrick DG, Koenen KC, Ruggiero KJ, et al. The serotonin transporter genotype 33 and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry 2007; 164:1693. 34 Broekman BF, Olff M, Boer F. The genetic background to PTSD. Neurosci Biobehav Rev 2007; 31:348.

Binder EB, Bradley RG, Liu W, et al. Association of FKBP5 polymorphisms and 35 childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008; 299:1291. Breslau N, Chilcoat HD, Kessler RC, Davis GC. Previous exposure to trauma and 36 PTSD effects of subsequent trauma: results from the Detroit Area Survey of Trauma. Am J Psychiatry 1999; 156:902. Schnyder U, Moergeli H, Klaghofer R, Buddeberg C. Incidence and prediction of 37 posttraumatic stress disorder symptoms in severely injured accident victims. Am J Psychiatry 2001; 158:594. Halbauer JD, Ashford JW, Zeitzer JM, et al. Neuropsychiatric diagnosis and 38 management of chronic sequelae of war-related mild to moderate traumatic brain injury. J Rehabil Res Dev 2009; 46:757. Schneiderman AI, Braver ER, Kang HK. Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and 39 Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder. Am J Epidemiol 2008; 167:1446. 40 Davidson JR, Hughes D, Blazer DG, George LK. Post-traumatic stress disorder in the community: an epidemiological study. Psychol Med 1991; 21:713.

Smid GE, Mooren TT, van der Mast RC, et al. Delayed posttraumatic stress disorder: 41 systematic review, meta-analysis, and meta-regression analysis of prospective studies. J Clin Psychiatry 2009; 70:1572. 42 Solomon SD, Davidson JR. Trauma: prevalence, impairment, service use, and cost. J Clin Psychiatry 1997; 58 Suppl 9:5.

Wilcox HC, Storr CL, Breslau N. Posttraumatic stress disorder and suicide attempts in 43 a community sample of urban american young adults. Arch Gen Psychiatry 2009; 66:305.

44 45

Bernal M, Haro JM, Bernert S, et al. Risk factors for suicidality in Europe: results from the ESEMED study. J Affect Disord 2007; 101:27. Taft CT, Watkins LE, Stafford J, et al. Posttraumatic stress disorder and intimate relationship problems: a meta-analysis. J Consult Clin Psychol 2011; 79:22.

Schnurr PP, Hayes AF, Lunney CA, et al. Longitudinal analysis of the relationship 46 between symptoms and quality of life in veterans treated for posttraumatic stress disorder. J Consult Clin Psychol 2006; 74:707. 47 48 49 50 51 52 53 Monson CM, Fredman SJ, Macdonald A, et al. Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial. JAMA 2012; 308:700. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, American Psychiatric Association, Washington, DC 2000. Hoge CW, Castro CA, Messer SC, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med 2004; 351:13. Wilson JF. Posttraumatic stress disorder needs to be recognized in primary care. Ann Intern Med 2007; 146:617. Weathers FW, Juska JA, Keane TM. The PTSD checklist - civilian version. Boston National Center for PTSD. Boston Veterans Affairs Medical Center 1991. Blanchard EB, Jones-Alexander J, Buckley TC, Forneris CA. Psychometric properties of the PTSD Checklist (PCL). Behav Res Ther 1996; 34:669. Weathers, FW, Huska, JA, Keane, TM. The PTSD Checklist Civilian Version (PCL-C) Boston, MA: National Center for PTSD (Boston Veterans Affairs Medical Center.1991.

Andrykowski MA, Cordova MJ, Studts JL, Miller TW. Posttraumatic stress disorder after treatment for breast cancer: prevalence of diagnosis and use of the PTSD 54 Checklist-Civilian Version (PCL-C) as a screening instrument. J Consult Clin Psychol 1998; 66:586. 55 Blake DD, Weathers FW, Nagy LM, et al. The development of a ClinicianAdministered PTSD Scale. J Trauma Stress 1995; 8:75. Topic 500 Version 11.0 All rights reserved.

You might also like